No AccessJournal of UrologyClinical Urology: Original Article1 Jan 1996Decrease in Mortality from Benign Prostatic Hyperplasia: a Major Unheralded Health Triumph Peter Boyle, Patrick Maisonneuve, and Adolphe Steg Peter BoylePeter Boyle More articles by this author , Patrick MaisonneuvePatrick Maisonneuve More articles by this author , and Adolphe StegAdolphe Steg More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)66587-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: A systematic examination of all available mortality data from benign prostatic hyperplasia (BPH) between 1950 and 1990 was done to estimate the changing international mortality pattern of this condition. Materials and Methods: Mortality data in which BPH was the underlying cause of death were abstracted from the World Health Organization mortality data base. These data were available from a variety of international countries (in many since 1950). Results: Mortality rates have decreased with considerable magnitude in developed western countries between the early 1950s and late 1980s. This fact could reasonably be attributed to the improved management of the most severe complications of BPH and to improvements in surgery and anesthesia, which have made surgical interventions of the prostate possible in a greater proportion of men, and safer in the immediate and subsequent postoperative period. Conclusions: The decreases noted in western countries, such as the United Kingdom (where 8,700 fewer men die each year presently than would be expected if the BPH mortality rates from the early 1950s still applied), United States (13,681 fewer deaths) and France (2,884 fewer deaths), indicate a considerable but unheralded achievement for modern medicine. Unfortunately, these decreases have not been observed to the same extent in central and eastern Europe and South America, where the residual high mortality rates could be lowered by education, and the widespread availability of modern surgical and anesthetic equipment. References 1 Trends in prostate cancer 1980-1988. Weekly Epidemiol Record1992; 67: 281. Google Scholar 2 : The development of human benign prostatic hyperplasia with age. J. Urol.1984; 132: 474. Link, Google Scholar 3 : High prevalence of benign prostatic hypertrophy in the community. Lancet1991; 338: 469. Crossref, Medline, Google Scholar 4 National Hospital Discharge Data Tapes.. Hyattsville, Maryland: National Center for Health Statistics1985. Google Scholar 5 : The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Amer. J. Epidemiol.1985; 121: 78. Medline, Google Scholar 6 : Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed. Eur. Urol.1991; 20: 3. Google Scholar 7 : Benign prostatic hyperplasia: antecedents and natural history. Epidemiol. Rev.1992; 14: 131. Google Scholar 8 Barry, M. J., Beckley, S., Boyle, P., Ghoniem, M., Gu, F. L., Guess, H. A., Oishi, K. and O'Leary, M. P.: Importance of understanding the epidemiology and natural history of BPH. In: Proceedings of International Consultation on BPH. Edited by A. T. K. Cockett, Y. Aso, C. Chatelain, L. Denis, K. Griffiths, S. Khoury and G. Murphy. pp. 13-21, 1991. Google Scholar 9 : Report on variation in rates of utilization of surgical services in the Commonwealth of Massachusetts. J.A.M.A.1985; 254: 371. Google Scholar 10 : An assessment of prostatectomy for benign urinary obstruction. Geographic variations and the evaluation of medical care outcomes. J.A.M.A.1988; 259: 3027. Google Scholar 11 : Small area variations in health care delivery. Science1973; 182: 1102. Google Scholar 12 : Medical outcomes research and benign prostatic hyperplasia. Prostate1990; 3: 61. Crossref, Google Scholar 13 : Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. New Engl. J. Med.1982; 307: 1310. Google Scholar 14 : Symptom status and quality of life following prostatectomy. J.A.M.A.1988; 259: 3018. Google Scholar 15 : Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. J.A.M.A.1987; 257: 933. Google Scholar 16 : Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. New Engl. J. Med.1989; 320: 1120. Google Scholar 17 : Elevated mortality following transurethral resection of the prostate for benign hypertrophy! But why?. Med Care1990; 28: 870. Google Scholar 18 : Problems of comorbidity in mortality after prostatectomy. J.A.M.A.1992; 267: 1077. Google Scholar 19 : Transurethral versus open prostatectomy: do these procedures apply to the same patients and the same disease? Eur. Urol.1991; 20: 173. Google Scholar 20 : Manuals of the International Statistical Classification of Diseases Injuries and Causes of Death, 6th revision.. Geneva: World Health Organisation1948. Google Scholar 21 : Manuals of the International Statistical Classification of Diseases Injuries and Causes of Death, 7th revision.. Geneva: World Health Organisation1958. Google Scholar 22 : Manuals of the International Statistical Classification of Diseases Injuries and Causes of Death, 8th revision.. Geneva: World Health Organisation1968. Google Scholar 23 : Manuals of the International Statistical Classification of Diseases Injuries and Causes of Death, 9th revision.. Geneva: World Health Organisation1975. Google Scholar 24 : Statistical methods for registries. In: Cancer Registration: Principles and Methods.. Edited by . Lyon, France: International Agency for Research on Cancer1991: 126. Google Scholar 25 : Chronicle of Achievements in the History of Benign Prostatic Hyperplasia.. Oxford: Oxford Clinical Communications1992. Google Scholar Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy, and Clinique Urologique, Hopital Cochin, Paris, France.© 1996 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 155Issue 1January 1996Page: 176-180 Advertisement Copyright & Permissions© 1996 by American Urological Association, Inc.Metrics Author Information Peter Boyle More articles by this author Patrick Maisonneuve More articles by this author Adolphe Steg More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Boyle et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: